PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10759004-0 2000 The effect of steroid and intravenous immunoglobulin on thrombopoietin levels in pediatric patients with immune thrombocytopenic purpura. Steroids 14-21 thrombopoietin Homo sapiens 56-70 10759004-3 2000 This study was conducted to measure the TPO levels of children with immune thrombocytopenic purpura (ITP) during steroid and immunoglobulin treatment. Steroids 113-120 thrombopoietin Homo sapiens 40-43 8950771-4 1996 We further assayed serum TPO levels sequentially during steroid treatment in patients with AMT and ITP. Steroids 56-63 thrombopoietin Homo sapiens 25-28 9829848-3 1998 Following steroid treatment, all values approached normal, i.e., TPO (20 [18.75] pg/ml) was increased and IL-6 (19.5 [13] pg/ml) and P-selectin (248 [172.5] ng/ml) were decreased, significantly. Steroids 10-17 thrombopoietin Homo sapiens 65-68 9690802-5 1998 The serum TPO level was negatively correlated only with the megakaryocyte count in the ITP patients, and the megakaryocyte count in the ITP patients who had good responses to the steroid therapy was higher than that in those who had poor responses. Steroids 179-186 thrombopoietin Homo sapiens 10-13 9690802-6 1998 These data suggest that serum TPO levels might be important for the prediction of the outcome of ITP patients who receive steroid therapy. Steroids 122-129 thrombopoietin Homo sapiens 30-33 9690802-0 1998 Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy. Steroids 104-111 thrombopoietin Homo sapiens 10-24 9690802-2 1998 The TPO levels of the 15 ITP patients who had a poor response to steroid therapy (i.e. an unchanged platelet count) were higher than those of the 22 ITP patients who had a good response to steroid therapy (i.e. an increased platelet count) and the normal subjects. Steroids 65-72 thrombopoietin Homo sapiens 4-7 9690802-2 1998 The TPO levels of the 15 ITP patients who had a poor response to steroid therapy (i.e. an unchanged platelet count) were higher than those of the 22 ITP patients who had a good response to steroid therapy (i.e. an increased platelet count) and the normal subjects. Steroids 189-196 thrombopoietin Homo sapiens 4-7 9690802-3 1998 The TPO levels in the 15 ITP patients whose platelet count was higher than 10 x 10(4)/microl after the discontinuation of steroid therapy significantly higher than those of the normal subjects. Steroids 122-129 thrombopoietin Homo sapiens 4-7